Middle East Healthcare Company (4009.SR)
SAR 71.8
(2.28%)
SAR 71.8
(2.28%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 342.49 Million SAR | 148.07% |
| 2022 | 140.34 Million SAR | 158.72% |
| 2021 | 54.24 Million SAR | -57.09% |
| 2020 | 126.4 Million SAR | 22.4% |
| 2019 | 103.26 Million SAR | -36.54% |
| 2018 | 162.73 Million SAR | -40.9% |
| 2017 | 275.36 Million SAR | -25.59% |
| 2016 | 370.08 Million SAR | -6.17% |
| 2015 | 394.43 Million SAR | 25.95% |
| 2014 | 313.17 Million SAR | 143.34% |
| 2013 | 128.69 Million SAR | 96.67% |
| 2012 | 65.43 Million SAR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 105.73 Million SAR | -10.12% |
| 2024 Q3 | 115.88 Million SAR | 9.6% |
| 2024 Q1 | 117.63 Million SAR | 34.98% |
| 2023 Q3 | 109.85 Million SAR | 59.23% |
| 2023 Q4 | 87.15 Million SAR | -20.66% |
| 2023 FY | 348.14 Million SAR | 148.07% |
| 2023 Q1 | 76.5 Million SAR | 35.75% |
| 2023 Q2 | 68.98 Million SAR | -9.83% |
| 2022 FY | 140.34 Million SAR | 158.72% |
| 2022 Q4 | 56.35 Million SAR | 109.23% |
| 2022 Q3 | 26.93 Million SAR | 23.73% |
| 2022 Q2 | 21.76 Million SAR | -38.29% |
| 2022 Q1 | 35.27 Million SAR | 670.02% |
| 2021 FY | 54.24 Million SAR | -57.09% |
| 2021 Q2 | 19.64 Million SAR | 12.28% |
| 2021 Q3 | 23.3 Million SAR | 18.63% |
| 2021 Q4 | -6.18 Million SAR | -126.56% |
| 2021 Q1 | 17.49 Million SAR | -43.82% |
| 2020 Q2 | 23.72 Million SAR | -2.62% |
| 2020 FY | 126.4 Million SAR | 22.4% |
| 2020 Q3 | 43.29 Million SAR | 82.46% |
| 2020 Q4 | 31.13 Million SAR | -28.07% |
| 2020 Q1 | 24.36 Million SAR | -44.7% |
| 2019 Q3 | 33.3 Million SAR | 339.22% |
| 2019 FY | 103.26 Million SAR | -36.54% |
| 2019 Q4 | 44.06 Million SAR | 32.28% |
| 2019 Q2 | 7.58 Million SAR | -58.59% |
| 2019 Q1 | 18.31 Million SAR | -23.58% |
| 2018 Q3 | 21.28 Million SAR | -32.76% |
| 2018 Q1 | 85.81 Million SAR | 49.64% |
| 2018 FY | 162.73 Million SAR | -40.9% |
| 2018 Q4 | 23.96 Million SAR | 12.57% |
| 2018 Q2 | 31.66 Million SAR | -63.11% |
| 2017 FY | 275.36 Million SAR | -25.59% |
| 2017 Q2 | 179.03 Million SAR | -15.09% |
| 2017 Q1 | 210.83 Million SAR | 136.11% |
| 2017 Q3 | 55.01 Million SAR | -69.27% |
| 2017 Q4 | 57.35 Million SAR | 4.24% |
| 2016 FY | 370.08 Million SAR | -6.17% |
| 2016 Q2 | 212.09 Million SAR | -2.05% |
| 2016 Q3 | 96.21 Million SAR | -54.64% |
| 2016 Q4 | 89.29 Million SAR | -7.19% |
| 2016 Q1 | 216.53 Million SAR | 110.09% |
| 2015 Q4 | 103.07 Million SAR | 12.4% |
| 2015 FY | 394.43 Million SAR | 25.95% |
| 2015 Q1 | 208.99 Million SAR | 166.67% |
| 2015 Q3 | 91.69 Million SAR | -55.02% |
| 2015 Q2 | 203.87 Million SAR | -2.45% |
| 2014 Q3 | 71.53 Million SAR | 0.0% |
| 2014 Q4 | 78.36 Million SAR | 9.56% |
| 2014 FY | 313.17 Million SAR | 143.34% |
| 2014 Q1 | 75.1 Million SAR | 0.0% |
| 2013 FY | 128.69 Million SAR | 96.67% |
| 2012 FY | 65.43 Million SAR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Mouwasat Medical Services Company | 756.85 Million SAR | 54.747% |
| Dallah Healthcare Company | 506.31 Million SAR | 32.354% |
| National Medical Care Company | 246.72 Million SAR | -38.819% |
| Al Hammadi Company For Development and Investment | 342.57 Million SAR | 0.022% |
| Dr. Sulaiman Al Habib Medical Services Group Company | 2.09 Billion SAR | 83.657% |
| Canadian General Medical Center Complex Company | 15.89 Million SAR | -2054.557% |
| Arabian International Healthcare Holding Company | 40.06 Million SAR | -754.818% |
| Future Care Trading Co. | 15.6 Million SAR | -2094.366% |
| Naba Alsaha Medical Services Company | 42.96 Million SAR | -697.119% |
| Lana Medical Co. | 4.56 Million SAR | -7398.739% |
| Al-Modawat Specialized Medical Co. | 23.35 Million SAR | -1366.512% |